Diagnostic Testing of STDs Market ,By Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, and Others), By Location of Testing (Laboratory Testing, POC Testing), By Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) — Market Size and Forecasting (2021–2030)

The Diagnostic Testing of STDs Market was valued at XX million in 2020 and is expected to reach USD million by 2030, at a CAGR of XX% during the forecast period. STDs are a type of severe health problem. Chlamydia, gonorrhea, and herpes simplex virus are the most common disease types. The diagnostic testing of STDs market is being driven by various educational campaigns and government initiatives aimed at increasing awareness about these diseases. A growing population having multiple partners and casual sex can lead to STDs and contribute to market growth.           

The diagnostics testing of STDs market is estimated to witness significant growth over the forecast period due to the introduction of technologically innovative products for diagnostics purposes that can provide accurate testing results. A significant change from traditional laboratory testing to a rapid point of care testing is also expected to drive market growth. Government measures targeted towards healthcare infrastructure improvement, especially in the emerging economies of Asia Pacific and MEA, are expected to boost the market growth over the forecast period.

Improvement of healthcare infrastructure and increasing per capita incomes are the factors that are driving healthcare reform, thereby supporting market growth. Innovative diagnosis and improvement in infrastructures for testing services have helped in providing quicker and accurate testing results. This is facilitating the better treatment for STDs.

Diagnostic Testing of STDs Market

Market Segmentation

The diagnostic testing of STDs market is segmented based on disease type, location of testing, and region

Diagnostic Testing of STDs Market, by Disease Type

Based on the disease type, the market is segmented into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus, and others. The gonorrhea segment is expected to dominate the market during the forecast period. Gonorrhea, caused by Neisseria gonorrhoeae, is the second most typical bacterial STI and results in considerable illness and economic expenses worldwide. It is also known as the clap. Gonorrhea is also diagnosed by physical examination, including pelvic exam in young women, thorough medical history, and laboratory testing of cervical, vaginal, or penile secretions.

The chlamydia segment is expected to grow at a high CAGR during the forecast period due to its increasing prevalence worldwide. Syphilis infected sexually transmitted diseases are also found to have increased in recent years, which is expected to contribute to the growth of this segment.

Diagnostic Testing of STDs Market, by Location of Testing

Based on the location of testing, the market is segmented into laboratory testing and point of care testing. The laboratory segment is expected to dominate the market owing to the growing number of laboratories offering STD testing.

The point of care (PoC) testing segment is expected to grow at the fastest rate during the forecast period due to preferential benefits as compared to laboratories. There is a perceptible shift from traditional laboratory tests to a quick and easy point of care (PoC) tests due to the benefits offered by the point of care testing devices. This can contribute to market growth.

Diagnostic Testing of STDs Market, By Region

Based on region, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa (MEA), and South America. The Asia Pacific accounted for a major market share in 2020 and is expected to continue its dominance during the forecast period. Factors driving market growth in this region include increasing prevalence of sexually transmitted infections in the Asia Pacific, coupled with impressive funding and programs which has put Asia Pacific on a growth chart.

North America is an established market for STD diagnostics owing to the rising prevalence of this infection, coupled with supportive government policies for market development. Large numbers of STD cases are a reminder to the growth of diagnostic testing of STD market in North America. Advancements in technologies to improve the diagnosis and treatment of STD would, in turn, support regional growth.

What does this Report Provide?

A detailed understanding of the diagnostic testing of STDs market demand from a qualitative and quantitative perspective. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the diagnostic testing of STDs market.

The major market drivers, challenges, and opportunities for the market have been covered in the report. This report also includes the market shares of the leading companies, their production capacities, and the growth strategies adopted by them.

Some Recent Developments in the Diagnostic Testing of STDs Market

  • In April 2020, binx health received a second 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its binx Io, a molecular point-of-care testing platform for the identification of chlamydia and gonorrhea.
  • In February 2020, Pinpoint Science Inc. merged with Analog Devices, Inc. to expand the development and manufacture of unique nanosensor diagnostics for infectious diseases.

Diagnostic Testing of STDs Market

Market Segmentation

By Disease Type

  • Chlamydia
  • Syphilis
  • Gonorrhea
  • Herpes Simplex Virus
  • Human Papilloma Virus
  • Human Immunodeficiency Virus
  • Others

By Location of Testing

  • Laboratory Testing
  • POC Testing

By Region

North America Diagnostic Testing of STDs Market

  • North America, by Country
    • The U.S.
    • Canada
    • Mexico
  • North America, by Disease Type
  • North America, by Location of Testing

Europe Diagnostic Testing of STDs Market

  • Europe, by Country
    • Germany
    • Russia
    • The U.K.
    • France
    • Italy
    • Spain
    • The Rest of Europe
  • Europe, by Disease Type
  • Europe, by Location of Testing

Asia Pacific Diagnostic Testing of STDs Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • The Rest of Asia Pacific
  • Asia Pacific, by Disease Type
  • Asia Pacific, by Location of Testing

Middle East and Africa Diagnostic Testing of STDs Market

  • Middle East and Africa, by Country
    • The UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • The Rest of Middle East and Africa
  • Middle East and Africa, by Disease Type
  • Middle East and Africa, by Location of Testing

South America Diagnostic Testing of STDs Market

  • South America, by Country
    • Brazil
    • Argentina
    • The Rest of South America
  • South America, by Disease Type
  • South America, by Location of Testing

Major Companies: The key players in diagnostic testing of STDs market are, Abbott Laboratories, MedMira Inc, Qaigen Inc, Cepheid, F. Hoffmann-La Roche AG, and Diasorin S.p.A.

Objectives of this Report:

  • To estimate the diagnostic testing of STDs market size on a regional and global basis
  • To identify major segments in the diagnostic testing of STDs market and evaluate their market shares and demand
  • To provide a competitive scenario for the global market with major developments observed by key companies in the historic years
  • To evaluate key factors governing the dynamics of diagnostic testing of STDs market with their potential gravity during the forecast period
  • To evaluate the leading company-wise pricing analysis for the mentioned applications

Customization:

This study is customized to meet your specific requirements:

  • By sub-segment
  • By client-specific country, type, and application market analysis
  • Pricing analysis along with the potential list of customers
  • Product-specific competitive analysis

Customization:

This study is customized to meet your specific requirements:

    • By Segment
    • By Sub-segment
    • By Region/Country
    • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com